There were 1,829 press releases posted in the last 24 hours and 402,705 in the last 365 days.

Robotics Technology In Interventional Oncology Devices Is Emerging Trend In The Market

Interventional Oncology Devices  Market Report 2021: COVID 19 Growth And Change To 2030

Interventional Oncology Devices Global Market Report 2021: COVID 19 Growth And Change To 2030

Interventional Oncology Devices Market Report 2021

Interventional Oncology Devices Global Market Report 2021

The Business Research Company’s Interventional Oncology Devices Global Market Report 2021: COVID-19 Growth And Change To 2030

LONDON, GREATER LONDON, UK, August 23, 2021 /EINPresswire.com/ -- Companies are focusing on deploying robotics technology in interventional oncology devices for higher efficiency. The robotic system integrates image-based planning and navigation with the installation of different instruments to the desired body part with better accuracy and efficiency. For instance, in November 2019, the first robotic device of XACT Robotics Ltd was approved in the United States by the Food and Drug Administration for use during computed tomography (CT) controlled percutaneous interventional procedures.

The market for interventional oncology devices comprises the sale of interventional oncology devices and related services by the entities that manufacture them. Interventional oncology devices are used to detect and treat cancer using minimally invasive procedures and advanced imaging technologies.

Major players covered in the global interventional oncology devices industry are Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Merit Medical Systems, Inc, Philips Volcano, AngioDynamics Inc., GE Healthcare, Siemens Healthineers, Sirtex Medical, Cook Medical Incorporated.

Read More On The Global Interventional Oncology Devices Market Report:
https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report-2020-30-COVID-19-growth-and-change

The global interventional oncology devices market size is expected to grow from $2.01 billion in 2020 to $2.23 billion in 2021 at a compound annual growth rate (CAGR) of 10.9%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $3.32 billion in 2025 at a CAGR of 10%.

The global interventional oncology devices market is segmented by product into embolization devices, ablation devices, support devices; by procedure into thermal tumor ablation, non-thermal tumor ablation, transcatheter arterial chemoembolization (TACE), transcatheter arterial radioembolization (TARE) or selective internal radiation therapy (SIRT), transcatheter arterial embolization (TAE) or bland embolization; by cancer type into liver cancer, kidney cancer, lung cancer, bone cancer, others.

Interventional Oncology Devices Global Market Report 2021: COVID-19 Growth And Change To 2030 is one of a series of new reports from The Business Research Company that provides interventional oncology devices market overview, forecast interventional oncology devices market size and growth for the whole market, interventional oncology devices market segments, and geographies, interventional oncology devices market trends, interventional oncology devices market drivers, restraints, leading competitors’ revenues, profiles, and market shares.

Request For A Sample Of The Global Interventional Oncology Devices Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3304&type=smp

Here Is A List Of Similar Reports By The Business Research Company:
Cancer Diagnostics Global Market Report 2021 - By Products (Companion Diagnostics, Molecular Diagnostics), By End-User (Cancer Research Institutes, Diagnostic Laboratories, Hospitals), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma), COVID-19 Growth And Change
(https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report)

Oncology Drugs Global Market Report 2021: COVID-19 Impact And Recovery To 2030
(https://www.thebusinessresearchcompany.com/report/oncology-drugs-global-market-report)

Oncology Devices Global Market Report 2021: COVID-19 Growth And Change To 2030
(https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report-2020-30-COVID-19-growth-and-change)

Interested to know more about The Business Research Company?
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Or get a quick glimpse of our services here: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

The Business Research Company
Email: info@tbrc.info
Follow us on LinkedIn: https://bit.ly/3b7850r
Follow us on Twitter: https://bit.ly/3b1rmjS
Check out our Blog: http://blog.tbrc.info/

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn